Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Condition(s):Acute GVHDLast Updated:February 22, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute GVHDLast Updated:February 22, 2023Recruiting
Condition(s):Atopic; DermatitisLast Updated:July 24, 2023Completed
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Unknown status
Condition(s):Liver Transplantation; Immunosuppression; Neurotoxicity; Tremor; TacrolimusLast Updated:October 22, 2021Not yet recruiting
Condition(s):Transplant;Failure,KidneyLast Updated:November 8, 2022Recruiting
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed
Condition(s):Heart Transplant Failure and RejectionLast Updated:May 19, 2023Recruiting
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Unknown status
Condition(s):HemochromatosisLast Updated:September 4, 2018Completed
Condition(s):Kidney TransplantationLast Updated:November 7, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.